Bobak R. Azamian
President/CEO and Board Chair at Tarsus Pharmaceuticals Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Tarsus Pharmaceuticals Inc., 3 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Tarsus Pharmaceuticals Inc. June 12, 202575.4%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 4, 2026 | Tarsus Pharmaceuticals Inc. | Open-market sale | −7,100 | $90.27 | $640,917 |
| Sep 4, 2026 | Tarsus Pharmaceuticals Inc. | Open-market sale | −2,900 | $91.27 | $264,683 |
| Sep 2, 2026 | Tarsus Pharmaceuticals Inc. | Open-market sale | −10,000 | $80.06 | $800,600 |
| Jun 17, 2026 | Tarsus Pharmaceuticals Inc. | Open-market sale | −4,582 | $61.24 | $280,602 |
| Jun 17, 2026 | Tarsus Pharmaceuticals Inc. | Open-market sale | −5,418 | $61.81 | $334,887 |
| Mar 19, 2026 | Tarsus Pharmaceuticals Inc. | Open-market sale | −11,964 | $67.00 | $801,588 |
| Mar 18, 2026 | Tarsus Pharmaceuticals Inc. | Open-market sale | −11,667 | $68.71 | $801,640 |
| Mar 17, 2026 | Tarsus Pharmaceuticals Inc. | Open-market sale | −10,972 | $69.42 | $761,676 |
| Mar 15, 2026 | Tarsus Pharmaceuticals Inc. | Option exercise | +66,274 | — | — |
| Dec 24, 2025 | Tarsus Pharmaceuticals Inc. | Open-market sale | −5,443 | $82.41 | $448,558 |
| Dec 24, 2025 | Tarsus Pharmaceuticals Inc. | Open-market sale | −557 | $83.54 | $46,532 |
| Dec 4, 2025 | Tarsus Pharmaceuticals Inc. | Gift | −51,885 | — | — |
| Sep 24, 2025 | Tarsus Pharmaceuticals Inc. | Open-market sale | −6,000 | $55.37 | $332,220 |
| Aug 11, 2025 | Tarsus Pharmaceuticals Inc. | Open-market sale | −6,000 | $50.00 | $300,000 |
| Mar 24, 2025 | Tarsus Pharmaceuticals Inc. | Open-market sale | −6,000 | $50.00 | $300,000 |
Questions about Bobak R. Azamian
What boards is Bobak R. Azamian on?
Bobak R. Azamian sits on the board of Tarsus Pharmaceuticals Inc.
What company is Bobak R. Azamian the CEO of?
Bobak R. Azamian is President/CEO and Board Chair of Tarsus Pharmaceuticals Inc.
How long has Bobak R. Azamian served on boards?
Our records show at least 4 years of board service across 1 board, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.